Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04915612. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05144243. IPD Sharing: YES. Countries: 1. Publications: 0.
Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant
ClinicalTrials.gov study NCT04836390. IPD Sharing: YES. Countries: 1. Publications: 0.
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT06379360. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
ClinicalTrials.gov study NCT03356080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00136461. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Evaluation of IBI188 in Combination With Demethylating Agents in Treatment of Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04485052. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation
ClinicalTrials.gov study NCT04691648. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of JNJ-67571244 in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT03915379. IPD Sharing: YES. Countries: 3. Publications: 0.
GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly
ClinicalTrials.gov study NCT00925873. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00577694. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00401739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Role of PTK-7 in Acute Myeloid Leukemias
ClinicalTrials.gov study NCT02860793. IPD Sharing: NO. Countries: 1. Publications: 0.
CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04265963. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT06852222. IPD Sharing: YES. Countries: 24. Publications: 0.
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01757639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00086099. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients
ClinicalTrials.gov study NCT07132684. IPD Sharing: NO. Countries: 1. Publications: 0.
Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05720988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04047641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.